Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bastien Jamet

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Cancers|June 3, 2020
FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?Anne-Victoire Michaud-Robert, Bastien Jamet, Clément Bailly, et al.
Oncotarget|November 5, 2017
Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumorsBastien Jamet, Thomas Carlier, Loic Campion, et al.
International Journal of Molecular Sciences|December 23, 2022
Semi-Quantitative [<sup>18</sup>F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell ArteritisOlivier Espitia, Jérémy Schanus, Christian Agard, et al.
International Journal of Molecular Sciences|August 6, 2020
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple MyelomaBastien Jamet, Elena Zamagni, Cristina Nanni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
EANM guidelines on the use of [<sup>18</sup>F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disordersCristina Nanni, Christophe M Deroose, Sona Balogova, et al.
Cancers|September 9, 2020
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III TrialsAnne-Victoire Michaud-Robert, Elena Zamagni, Thomas Carlier, et al.
International Journal of Molecular Sciences|February 21, 2017
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma PatientsClément Bailly, Rodolphe Leforestier, Bastien Jamet, et al.
Haematologica|July 20, 2023
Immune-related adverse events with bispecific T-cell engager therapy targeting B-cell maturation antigenBénédicte Piron, Mathilde Bastien, Chloé Antier, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 11, 2024
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approachBastien Jamet, Hatem Necib, Thomas Carlier, et al.
Frontiers in Medicine|April 27, 2019
Interest of Pet Imaging in Multiple MyelomaBastien Jamet, Clément Bailly, Thomas Carlier, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancers|June 3, 2020
FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?Anne-Victoire Michaud-Robert, Bastien Jamet, Clément Bailly, et al.
Oncotarget|November 5, 2017
Initial FDG-PET/CT predicts survival in adults Ewing sarcoma family of tumorsBastien Jamet, Thomas Carlier, Loic Campion, et al.
International Journal of Molecular Sciences|December 23, 2022
Semi-Quantitative [<sup>18</sup>F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell ArteritisOlivier Espitia, Jérémy Schanus, Christian Agard, et al.
International Journal of Molecular Sciences|August 6, 2020
Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple MyelomaBastien Jamet, Elena Zamagni, Cristina Nanni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2024
EANM guidelines on the use of [<sup>18</sup>F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disordersCristina Nanni, Christophe M Deroose, Sona Balogova, et al.
Cancers|September 9, 2020
Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III TrialsAnne-Victoire Michaud-Robert, Elena Zamagni, Thomas Carlier, et al.
International Journal of Molecular Sciences|February 21, 2017
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma PatientsClément Bailly, Rodolphe Leforestier, Bastien Jamet, et al.
Haematologica|July 20, 2023
Immune-related adverse events with bispecific T-cell engager therapy targeting B-cell maturation antigenBénédicte Piron, Mathilde Bastien, Chloé Antier, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 11, 2024
DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approachBastien Jamet, Hatem Necib, Thomas Carlier, et al.
Frontiers in Medicine|April 27, 2019
Interest of Pet Imaging in Multiple MyelomaBastien Jamet, Clément Bailly, Thomas Carlier, et al.
Pageof 5